½ÃÀ庸°í¼­
»óǰÄÚµå
1417461

Á¤¸Æ-Á¤¸Æ ü¿Ü½Ä »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2030³â)

Veno-Venous Extracorporeal Life Support Device Market Report: Trends, Forecast and Competitive Analysis to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Lucintel | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 - page report | ¹è¼Û¾È³» : 3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Á¤¸Æ-Á¤¸Æ ü¿Ü½Ä »ý¸íÀ¯ÁöÀåÄ¡ÀÇ µ¿Çâ°ú ¿¹Ãø

¼¼°èÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü½Ä »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀåÀº 2024-2030³â CAGR 6.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ½ÉÇ÷°üÁúȯ ¹× ½ÉÆó ÁúȯÀ» ¾Î´Â ¸¹Àº ȯÀÚ¿Í ³ëÀÎ Àα¸ÀÇ ³ôÀº Áõ°¡ÀÔ´Ï´Ù. ¼¼°èÀÇ Á¤¸Æ ü¿Ü½Ä »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀåÀÇ ¹Ì·¡´Â º´¿ø ¹× Áø·á¼Ò ½ÃÀå¿¡¼­ÀÇ ±âȸ·Î À¯¸Á½ÃµÇ°í ÀÖ½À´Ï´Ù.

Á¤¸Æ-Á¤¸Æ ü¿Ü½Ä »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀå ÀλçÀÌÆ®

LucintelÀÇ ¿¹Ãø¿¡¼­´Â ´Ü½É½Ç µð¹ÙÀ̽º´Â ´Ü½É½Ç ½ÉÀå °áÇÔÀÇ À¯º´·ü »ó½Â¿¡ ÀÇÇØ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù.

ÀÌ ½ÃÀå¿¡¼­ º´¿øÀº Àü¹®ÀûÀÎ ±â±â¿Í ÈÆ·ÃµÈ ÀÎÀç°¡ º´¿ø¿¡ ¸¹ÀÌ Á¸ÀçÇϹǷΠÃÖ´ë ºÎ¹®À» À¯ÁöÇÒ °ÍÀ¸·Î »ý°¢µË´Ï´Ù.

ºÏ¹Ì´Â °í·ÉÀÚ Àα¸ÀÇ Áõ°¡¿Í ½ÉÆó ÁúȯÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù.

ÀÚÁÖ ¹¯´Â Áú¹®

Q1.½ÃÀåÀÇ ¼ºÀå ¿¹ÃøÀº?

A1.¼¼°èÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü½Ä »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀåÀº 2024-2030³â CAGR 6.5%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

Q2.½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎÀº?

A2.ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ½ÉÇ÷°üÁúȯ ¹× ½ÉÆó ÁúȯÀ» ¾Î´Â ¸¹Àº ȯÀÚ¿Í ³ëÀÎ Àα¸ÀÇ ³ôÀº Áõ°¡ÀÔ´Ï´Ù.

Q3.½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº?

A3.Á¤¸Æ-Á¤¸Æ ü¿Ü½Ä »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀåÀÇ ¹Ì·¡´Â º´¿ø°ú Áø·á¼Ò ½ÃÀå¿¡¼­ÀÇ ±âȸ·Î À¯¸Á½ÃµÇ°í ÀÖ½À´Ï´Ù.

Q4.½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?

A4.ÁÖ¿ä Á¤¸Æ-Á¤¸Æ ü¿Ü½Ä »ý¸íÀ¯ÁöÀåÄ¡ ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù.

  • Aquetholding
  • Microport Scientific
  • Medos Medizintechnik
  • Sorin
  • Medtronic

Q5.ÇâÈÄ ÃÖ´ë°¡ µÇ´Â ½ÃÀå ºÎ¹®Àº?

A5.LucintelÀº ´Ü½É½Ç µð¹ÙÀ̽º´Â ´Ü½É½Ç ½ÉÀå °áÇÔÀÇ À¯º´·ü »ó½Â¿¡ ÀÇÇØ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù.

Q6.½ÃÀå¿¡¼­ ÇâÈÄ 5³â°£ ÃÖ´ë°¡ µÉ °ÍÀ¸·Î ¿¹»óµÇ´Â Áö¿ªÀº?

A6.ºÏ¹Ì´Â °í·ÉÀÚ Àα¸ÀÇ Áõ°¡¿Í ½ÉÆó ÁúȯÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù.

Q7.¸®Æ÷Æ®ÀÇ Ä¿½ºÅ͸¶ÀÌÁî´Â °¡´É?

A7.³×, LucintelÀº Ãß°¡ ºñ¿ë ¾øÀÌ 10%ÀÇ Ä¿½ºÅ͸¶ÀÌÁ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀå : ½ÃÀå ¿ªÇÐ

  • ¼­·Ð, ¹è°æ, ºÐ·ù
  • °ø±Þ¸Á
  • ¾÷°èÀÇ ÃËÁø¿äÀΰú °úÁ¦

Á¦3Àå 2018-2030³â ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®

  • °Å½Ã°æÁ¦ µ¿Çâ(2018-2023³â)°ú ¿¹Ãø(2024-2030³â)
  • ¼¼°èÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀå µ¿Çâ(2018-2023³â)°ú ¿¹Ãø(2024-2030³â)
  • ¼¼°èÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀå, À¯Çüº°
    • ´Ü½É½Ç µð¹ÙÀ̽º
    • ¾ç½É½Ç µð¹ÙÀ̽º
  • ¼¼°èÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀå, ¿ëµµº°
    • ´ëÅð Á¤¸Æ
    • °æÁ¤¸Æ
    • ¿ì½É¹æ
    • ±âŸ
  • ¼¼°èÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀå, ÃÖÁ¾ ¿ëµµ »ê¾÷º°
    • º´¿ø
    • Ŭ¸®´Ð
    • ±âŸ

Á¦4Àå 2018-2030³âÀÇ Áö¿ªº° ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®

  • Áö¿ªº° ¼¼°èÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀå
  • ºÏ¹ÌÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀå
  • À¯·´ÀÇ Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀå
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀå
  • ±âŸ Áö¿ªÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀå

Á¦5Àå °æÀïÀÇ ºÐ¼®

  • Á¦Ç° Æ÷Æ®Æú¸®¿À ºÐ¼®
  • ¿î¿µ»ó ÅëÇÕ
  • Porter's Five Forces ºÐ¼®

Á¦6Àå ¼ºÀå ±âȸ¿Í Àü·«Àû ºÐ¼®

  • ¼ºÀå ±âȸ ºÐ¼®
    • À¯Çüº° ¼¼°èÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀåÀÇ ¼ºÀå ±âȸ
    • ¿ëµµº° ¼¼°èÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀåÀÇ ¼ºÀå ±âȸ
    • ÃÖÁ¾ ¿ëµµ »ê¾÷º° ¼¼°èÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀåÀÇ ¼ºÀå ±âȸ
    • Áö¿ªº° ¼¼°èÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀåÀÇ ¼ºÀå ±âȸ
  • ¼¼°èÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ
  • Àü·«Àû ºÐ¼®
    • ½ÅÁ¦Ç°ÀÇ °³¹ß
    • ¼¼°èÀÇ Á¤¸Æ-ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀåÀÇ ´É·Â È®´ë
    • ¼¼°èÀÇ Á¤¸Æ-Á¤¸Æ ü¿Ü »ý¸íÀ¯ÁöÀåÄ¡ ½ÃÀå¿¡¼­ÀÇ ÇÕº´, Àμö, ÇÕº´»ç¾÷
    • ÀÎÁõ°ú ¶óÀ̼±½Ì

Á¦7Àå À¯·Â ±â¾÷ÀÇ ±â¾÷ °³¿ä

  • AQUETHolding
  • Microport Scientific
  • Medos Medizintechnik
  • Sorin
  • Medtronic
KSA 24.03.11

Veno-Venous Extracorporeal Life Support Device Trends and Forecast

The future of the global veno-venous extracorporeal life support device market looks promising with opportunities in the hospitals and clinic markets. The global veno-venous extracorporeal life support device market is expected to grow with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are large number of patient suffering from cardiovascular and cardiopulmonary diseases and high growth of geriatric population.

A more than 150-page report is developed to help in your business decisions.

Veno-Venous Extracorporeal Life Support Device by Segment

The study includes a forecast for the global veno-venous extracorporeal life support device by type, application, end use industry, and region.

Veno-Venous Extracorporeal Life Support Device Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Single-Ventricular Device
  • Biventricular Device

Veno-Venous Extracorporeal Life Support Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Femoral Vein
  • Jugular Vein
  • Right Atrium
  • Others

Veno-Venous Extracorporeal Life Support Device Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Others

Veno-Venous Extracorporeal Life Support Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Veno-Venous Extracorporeal Life Support Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies veno-venous extracorporeal life support device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the veno-venous extracorporeal life support device companies profiled in this report include-

  • Aquetholding
  • Microport Scientific
  • Medos Medizintechnik
  • Sorin
  • Medtronic

Veno-Venous Extracorporeal Life Support Device Market Insights

Lucintel forecasts that single-ventricular devices is expected to witness highest growth over the forecast period due to rising prevalence of single-ventricle heart defects.

Within this market, hospitals will remain the largest segment due to high availability of specialized equipment and trained personnel in hospitals.

North America is expected to witness highest growth over the forecast period due to rising elderly population and high prevalence of cardiopulmonary disease.

Features of the Global Veno-Venous Extracorporeal Life Support Device Market

Market Size Estimates: Veno-venous extracorporeal life support device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Veno-venous extracorporeal life support device market size by type, application, end use industry, and region in terms of value ($B).

Regional Analysis: Veno-venous extracorporeal life support device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use industry, and regions for the veno-venous extracorporeal life support device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the veno-venous extracorporeal life support device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for veno-venous extracorporeal life support device market?

Answer: The global veno-venous extracorporeal life support device market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the veno-venous extracorporeal life support device market?

Answer: The major drivers for this market are large number of patient suffering from cardiovascular and cardiopulmonary diseases and high growth of geriatric population.

Q3. What are the major segments for veno-venous extracorporeal life support device market?

Answer: The future of the veno-venous extracorporeal life support device market looks promising with opportunities in the hospitals and clinic markets.

Q4. Who are the key veno-venous extracorporeal life support device market companies?

Answer: Some of the key veno-venous extracorporeal life support device companies are as follows.

  • Aquetholding
  • Microport Scientific
  • Medos Medizintechnik
  • Sorin
  • Medtronic

Q5. Which veno-venous extracorporeal life support device market segment will be the largest in future?

Answer: Lucintel forecasts that single-ventricular devices is expected to witness highest growth over the forecast period due to rising prevalence of single-ventricle heart defects.

Q6. In veno-venous extracorporeal life support device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to rising elderly population and high prevalence of cardiopulmonary disease.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the veno-venous extracorporeal life support device market by type (single-ventricular device and biventricular device), application (femoral vein, jugular vein, right atrium, and others), end use industry (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Veno-Venous Extracorporeal Life Support Device Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Veno-Venous Extracorporeal Life Support Device Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Veno-Venous Extracorporeal Life Support Device Market by Type
    • 3.3.1: Single-Ventricular Device
    • 3.3.2: Biventricular Device
  • 3.4: Global Veno-Venous Extracorporeal Life Support Device Market by Application
    • 3.4.1: Femoral Vein
    • 3.4.2: Jugular Vein
    • 3.4.3: Right Atrium
    • 3.4.4: Others
  • 3.5: Global Veno-Venous Extracorporeal Life Support Device Market by End Use Industry
    • 3.5.1: Hospitals
    • 3.5.2: Clinics
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Veno-Venous Extracorporeal Life Support Device Market by Region
  • 4.2: North American Veno-Venous Extracorporeal Life Support Device Market
    • 4.2.2: North American Veno-Venous Extracorporeal Life Support Device Market by End Use Industry: Hospitals, Clinics, and Others
  • 4.3: European Veno-Venous Extracorporeal Life Support Device Market
    • 4.3.1: European Veno-Venous Extracorporeal Life Support Device Market by Type: Single-Ventricular Device and Biventricular Device
    • 4.3.2: European Veno-Venous Extracorporeal Life Support Device Market by End Use Industry: Hospitals, Clinics, and Others
  • 4.4: APAC Veno-Venous Extracorporeal Life Support Device Market
    • 4.4.1: APAC Veno-Venous Extracorporeal Life Support Device Market by Type: Single-Ventricular Device and Biventricular Device
    • 4.4.2: APAC Veno-Venous Extracorporeal Life Support Device Market by End Use Industry: Hospitals, Clinics, and Others
  • 4.5: ROW Veno-Venous Extracorporeal Life Support Device Market
    • 4.5.1: ROW Veno-Venous Extracorporeal Life Support Device Market by Type: Single-Ventricular Device and Biventricular Device
    • 4.5.2: ROW Veno-Venous Extracorporeal Life Support Device Market by End Use Industry: Hospitals, Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Veno-Venous Extracorporeal Life Support Device Market by Type
    • 6.1.2: Growth Opportunities for the Global Veno-Venous Extracorporeal Life Support Device Market by Application
    • 6.1.3: Growth Opportunities for the Global Veno-Venous Extracorporeal Life Support Device Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Veno-Venous Extracorporeal Life Support Device Market by Region
  • 6.2: Emerging Trends in the Global Veno-Venous Extracorporeal Life Support Device Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Veno-Venous Extracorporeal Life Support Device Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Veno-Venous Extracorporeal Life Support Device Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: AQUETHolding
  • 7.2: Microport Scientific
  • 7.3: Medos Medizintechnik
  • 7.4: Sorin
  • 7.5: Medtronic
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦